InvestorsHub Logo
Followers 83
Posts 16210
Boards Moderated 3
Alias Born 12/02/2007

Re: None

Wednesday, 05/19/2021 2:11:17 PM

Wednesday, May 19, 2021 2:11:17 PM

Post# of 3880
The next step towards the reverse merger.

STEPHEN MILLS Attorney at Law PO Box 281077 Nashville, TN 37228 615-476-1151
May 18, 2021
OTC MARKET GROUPS, INC.
AXIS TECHNOLOGIES GROUP INC. (AXTG) RE: ANNUAL DISCLOSURE 2020
We have acted as counsel to AXTG (the "Company") on specific securities and corporate issues and were retained for the purpose of reviewing the current information supplied by the Company. We are domiciled and licensed in the State of Tennessee. We are residents of the United States. OTC Markets may rely upon this letter in determining whether the Company has made adequate current Information publicly available in accordance with Rule 144 (c) (2) under the Securities Act of 1933. Neither Attorney Stephen Mills nor any person associated with his law firm owns any shares of issuer’s securities and has never received or has any agreement to receive any of the issuer’s stock in payment for services.
We have (i) personally interviewed via phone conference the management and all directors of the Company, more specifically Caren Currier, all owners of 5% or greater of the outstanding stock which include Kipton Hirschbach and James Erickson, (ii) reviewed the annual financials ended December 31, 2020 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2021, reviewed the annual financials ended December 31, 2020 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2021, reviewed the quarterly financials ended March 31, 2021 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2021,

reviewed the quarterly financials ended September 30, 2020 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2021, reviewed the quarterly financials ended June 30, 2020 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2021, reviewed the quarterly financials ended March 31, 2020 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2021, reviewed the quarterly financials ended September 30, 2019 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2021, reviewed the quarterly financials ended June 30, 2019 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2021, reviewed the quarterly financials ended March 31, 2019 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2019, (iii) discussed the information with management and the director(s) of the Company.
To the best of our knowledge, after inquiry of management, including the Chief Executive Officer and the Board of Directors, neither the Issuer, the 5% holders of securities of the Company, nor the corporate counsel are currently under investigation by any federal or state regulatory authority for any violation of federal or state securities laws. There are no other family relationships or related party transactions with AXTG to disclose in its filings or in the Attorney letter. The company has not received any request for information or inquiries of any kind from the SEC or FINRA and are unaware of any request or inquiries from the SEC or FINRA since December 31, 2018. There are no pending corporate actions.
This letter covers the laws of the United States and does not depend on another law firm’s opinion or letter. We are permitted to practice before the Securities and Exchange Commission without prohibition. Attorney Stephen Mills is not currently, or has been within the past five years, been the subject of an investigation, hearing, or proceeding by the SEC, the US Commodity Futures Trading Commission, (CFTC), the Financial Industry Regulatory

Authority, (FINRA) or any other federal, state, or foreign regulatory agency. Attorney Stephen Mills is not currently, or has been within the past five years, been suspended or barred from practicing in any jurisdiction and has not been charged in a civil or criminal case. A representative of the Company is responsible for the preparation of the financial statements in accordance with GAAP, under the supervision of the CEO and are unaudited.
We may rely on information obtained from public officials, officers of the Company and we believe that these sources are reliable. In rendering this letter, we have examined the following:
1. Corporate records and other documents of the company.
Financial documents including: Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the year ending December 31, 2020, Financial documents including: Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the year ending December 31, 2019, Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the quarter ending March 31, 2021, Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the quarter ending September 30, 2020, Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the quarter ending June 30, 2020, Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the quarter ending March 31, 2020, Balance Sheet, Statement of

Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the quarter ending September 30, 2019, Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the quarter ending June 30, 2019, Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the quarter ending March 31, 2019. We may rely on information obtained from public officials, officers of the Company and we believe that these sources are reliable.
2. The financial documents were prepared by Caren Currier. Ms. Currier is an accountant whose address is Holy Hill Lane, Denton, TX 76205 626-429-2780. Ms. Currier is a former CFO of a public company and has over 25 years’ experience as an accountant. The financial statements are not audited and were prepared using documents provided to Ms. Currier by the company.
3. Representations made to us by the officers and directors of the Company which we deem as reliable.
4.
5.
Review of the Shareholders’ list provided by the Company’s transfer agent: Pacific Stock Transfer Co., 6725 Via Austi Parkway, Suite 300, Las Vegas, NV 89119, 800-785-7782 indicating the shares outstanding and confirming that Pacific Stock Transfer Co. is registered with Securities and Exchange Commission.
This letter is governed by and shall be interpreted in accordance with the Legal Opinion Accord (the “Accord”) of the American Bar Association Section of Business Law (1991). Therefore, it is subject to a number of qualifications, exceptions, definitions, limitation on coverage, and other limitations, all as more particularly described in the Accord, and this letter should be read in conjunction therewith. The law relevant to the opinions expressed herein is

limited to the laws of the United States of America.
Based upon the foregoing and subject to the qualifications hereinafter set forth, we are of the
opinion that the initial Company Information and Disclosure Statement:
1. Constitutes “adequate current public information” concerning the securities and the Company
“is available” within the meaning of Rule 144 (c) (2) under the Securities Act of 1933.
2. Includes all the information that a broker-dealer would be required to obtain from the
Company to publish a quotation for the securities under Rule 15c2-11 under the Securities
Exchange Act of 1934.
3. Complies as to form with the OTC Market Guidelines for providing adequate Current
Information, which are located on the internet at www.otcmarkets.com.
4. Has been posted through the OTC Disclosure and News Service; and
5. Pacific Stock Transfer Co. is registered under the Securities and Exchange Act of 1934.
6. The company currently does meet the definition of a shell corporation. Rule 405 of the
Securities Act of 1933 and Rule 12b-2 of the Securities Exchange Act of 1934 defines a shell company as a company with 1) no or nominal operations and either 2) no or nominal assets, 3) assets consisting solely of cash and cash equivalents or 4) assets consisting of any amount of cash and cash equivalents and nominal other assets.
7. This letter may be relied on by OTC Markets, Inc. but may not be used or relied upon by any other person for any other purpose whatsoever, without in each instance our prior
written consent. OTC Markets may publish this letter through OTC Disclosure and News Service for viewing by the public or regulators.
Sincerely,
Stephen Mills, Esq.STEPHEN MILLS Attorney at Law PO Box 281077 Nashville, TN 37228 615-476-1151
May 18, 2021
OTC MARKET GROUPS, INC.
AXIS TECHNOLOGIES GROUP INC. (AXTG) RE: ANNUAL DISCLOSURE 2020
We have acted as counsel to AXTG (the "Company") on specific securities and corporate issues and were retained for the purpose of reviewing the current information supplied by the Company. We are domiciled and licensed in the State of Tennessee. We are residents of the United States. OTC Markets may rely upon this letter in determining whether the Company has made adequate current Information publicly available in accordance with Rule 144 (c) (2) under the Securities Act of 1933. Neither Attorney Stephen Mills nor any person associated with his law firm owns any shares of issuer’s securities and has never received or has any agreement to receive any of the issuer’s stock in payment for services.
We have (i) personally interviewed via phone conference the management and all directors of the Company, more specifically Caren Currier, all owners of 5% or greater of the outstanding stock which include Kipton Hirschbach and James Erickson, (ii) reviewed the annual financials ended December 31, 2020 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2021, reviewed the annual financials ended December 31, 2020 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2021, reviewed the quarterly financials ended March 31, 2021 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2021,

reviewed the quarterly financials ended September 30, 2020 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2021, reviewed the quarterly financials ended June 30, 2020 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2021, reviewed the quarterly financials ended March 31, 2020 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2021, reviewed the quarterly financials ended September 30, 2019 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2021, reviewed the quarterly financials ended June 30, 2019 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2021, reviewed the quarterly financials ended March 31, 2019 and filed with the OTC disclosure News Service on www.OTCmarkets.com and posted on May 1, 2019, (iii) discussed the information with management and the director(s) of the Company.
To the best of our knowledge, after inquiry of management, including the Chief Executive Officer and the Board of Directors, neither the Issuer, the 5% holders of securities of the Company, nor the corporate counsel are currently under investigation by any federal or state regulatory authority for any violation of federal or state securities laws. There are no other family relationships or related party transactions with AXTG to disclose in its filings or in the Attorney letter. The company has not received any request for information or inquiries of any kind from the SEC or FINRA and are unaware of any request or inquiries from the SEC or FINRA since December 31, 2018. There are no pending corporate actions.
This letter covers the laws of the United States and does not depend on another law firm’s opinion or letter. We are permitted to practice before the Securities and Exchange Commission without prohibition. Attorney Stephen Mills is not currently, or has been within the past five years, been the subject of an investigation, hearing, or proceeding by the SEC, the US Commodity Futures Trading Commission, (CFTC), the Financial Industry Regulatory

Authority, (FINRA) or any other federal, state, or foreign regulatory agency. Attorney Stephen Mills is not currently, or has been within the past five years, been suspended or barred from practicing in any jurisdiction and has not been charged in a civil or criminal case. A representative of the Company is responsible for the preparation of the financial statements in accordance with GAAP, under the supervision of the CEO and are unaudited.
We may rely on information obtained from public officials, officers of the Company and we believe that these sources are reliable. In rendering this letter, we have examined the following:
1. Corporate records and other documents of the company.
Financial documents including: Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the year ending December 31, 2020, Financial documents including: Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the year ending December 31, 2019, Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the quarter ending March 31, 2021, Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the quarter ending September 30, 2020, Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the quarter ending June 30, 2020, Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the quarter ending March 31, 2020, Balance Sheet, Statement of

Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the quarter ending September 30, 2019, Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the quarter ending June 30, 2019, Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements for the quarter ending March 31, 2019. We may rely on information obtained from public officials, officers of the Company and we believe that these sources are reliable.
2. The financial documents were prepared by Caren Currier. Ms. Currier is an accountant whose address is Holy Hill Lane, Denton, TX 76205 626-429-2780. Ms. Currier is a former CFO of a public company and has over 25 years’ experience as an accountant. The financial statements are not audited and were prepared using documents provided to Ms. Currier by the company.
3. Representations made to us by the officers and directors of the Company which we deem as reliable.
4.
5.
Review of the Shareholders’ list provided by the Company’s transfer agent: Pacific Stock Transfer Co., 6725 Via Austi Parkway, Suite 300, Las Vegas, NV 89119, 800-785-7782 indicating the shares outstanding and confirming that Pacific Stock Transfer Co. is registered with Securities and Exchange Commission.
This letter is governed by and shall be interpreted in accordance with the Legal Opinion Accord (the “Accord”) of the American Bar Association Section of Business Law (1991). Therefore, it is subject to a number of qualifications, exceptions, definitions, limitation on coverage, and other limitations, all as more particularly described in the Accord, and this letter should be read in conjunction therewith. The law relevant to the opinions expressed herein is

limited to the laws of the United States of America.
Based upon the foregoing and subject to the qualifications hereinafter set forth, we are of the
opinion that the initial Company Information and Disclosure Statement:
1. Constitutes “adequate current public information” concerning the securities and the Company
“is available” within the meaning of Rule 144 (c) (2) under the Securities Act of 1933.
2. Includes all the information that a broker-dealer would be required to obtain from the
Company to publish a quotation for the securities under Rule 15c2-11 under the Securities
Exchange Act of 1934.
3. Complies as to form with the OTC Market Guidelines for providing adequate Current
Information, which are located on the internet at www.otcmarkets.com.
4. Has been posted through the OTC Disclosure and News Service; and
5. Pacific Stock Transfer Co. is registered under the Securities and Exchange Act of 1934.
6. The company currently does meet the definition of a shell corporation. Rule 405 of the
Securities Act of 1933 and Rule 12b-2 of the Securities Exchange Act of 1934 defines a shell company as a company with 1) no or nominal operations and either 2) no or nominal assets, 3) assets consisting solely of cash and cash equivalents or 4) assets consisting of any amount of cash and cash equivalents and nominal other assets.
7. This letter may be relied on by OTC Markets, Inc. but may not be used or relied upon by any other person for any other purpose whatsoever, without in each instance our prior
written consent. OTC Markets may publish this letter through OTC Disclosure and News Service for viewing by the public or regulators.
Sincerely,
Stephen Mills, Esq.